The search for cancer cure continues and one study reveals great news regarding breast cancer. The Harry Perkins Institute of Medical Research discovered that venom from honeybee can kill aggressive breast cancer cells within 60 minutes!
In the study that was published in the NPJ Nature Precision Oncology journal, the researcher Dr. Ciara Duffy stated that a compound in the bee’s venom can rapidly kill cancer cells. This is even the aggressive types - the ones that are considered hard to treat breast cancer cells.
The effectiveness of honeybee in treating breast cancer
The researchers see the honeybee as an effective cancer cure for breast tumors. They also tested the venom’s effects when combined with chemotherapy medicines and found astonishing results when it showed efficiency in reducing the growth of the tumor.
Then again, this was only tried in mice at this point. They said that they still have a long way to go but they are getting there as they push through with their aim to find a cancer cure after this exciting discovery.
Dr. Duffy is hoping that this research will lead to the development of cancer cure for triple-negative breast cancer that currently has no clinically effective treatment or therapies yet. She stated that the honeybee venom could be the answer after being proven to be extremely potent.
“We found that the venom from honeybees is remarkably effective in killing some of these really aggressive breast cancer cells at concentrations which aren't as damaging to normal cells," the doctor said via press release.
How they carried out the research
In the tests, the researchers synthetically reproduced the melittin, a major component of bee venom. They discovered it showed the same anti-cancer effects of the venom.
"We tested a very small, positively charged peptide in melittin, which we could reproduce synthetically, and found that the synthetic product mirrored the majority of the anti-cancer effects of honeybee venom," Dr. Duffy said. "We found both honeybee venom and melittin significantly, selectively and rapidly reduced the viability of triple-negative breast cancer and HER2-enriched breast cancer cells.”
This simply means that they found the bee venom to be powerful. In fact, the effects of the venom start within the first 20 minutes where it shuts down the pathways for the reproduction of the cancer cells.


US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Trump Signs Order to Cut Routine Childhood Vaccines
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
U.S. Issues Cuba Health Alert as Illnesses Rise
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal 



